Abstract
In 2023 the National Cervical Screening Programme (NCSP) in New Zealand will change from cytology testing to human papilloma virus (HPV) testing with the option of self-testing being offered to eligible women. The WHO has recommended this change in the belief that HPV testing will make cervical screening more acceptable for women. It is surmised this will lead to an increase in participation in screening programs which will in turn lead to an increase in early detection of cervical cancer and a reduction in mortality.
This cross-sectional study aimed to determine if women in a semi-rural area of New Zealand would consider the HPV swab an acceptable option in comparison to the current clinician completed cytology testing. A survey was developed and distributed to women at a selected general practice in the South Island. The results of this survey demonstrate a strong acceptance to HPV testing and to the potential option of completing this test independently and in their own homes. Open question comments were consistent with previous research on the barriers to screening which allows insight into the reasons why women have not been attending for the recommended screening. This data will assist health care providers to introduce the concept of primary HPV screening to women and to determine what education is required to encourage participation, with the ultimate goal to reduce the incidence of cervical cancer in New Zealand.